Shanghai Allist Pharmaceuticals Hits Day Low at CNY 92.81 Amid Price Pressure

Shanghai Allist Pharmaceuticals Co., Ltd. experienced a notable decline today, with the stock dropping by 3.39% on March 9, 2026. The stock reached an intraday low of CNY 92.81, reflecting a challenging trading session for the company. Despite this day's downturn, Shanghai Allist has shown resilience over the past week, with a performance increase of 3.44%, contrasting with a decline in the China Shanghai Composite, which fell by 2.06%. Over the past month, the stock has decreased by 1.64%, while the one-year performance stands at a gain of 13.59%, albeit below the composite's 21.47% increase. The company maintains a strong market position within the pharmaceuticals and biotechnology sector, boasting a market capitalization of CNY 43,056 million. Key financial metrics include a return on equity of 29.94% and a price-to-earnings ratio of 27.00. Additionally, Shanghai Allist has reported impressive growth in net profit and operating cash flow over recent quarters, indicating a solid operational foundation despite today's stock performance.